Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The objective of the present study is to evaluate both the efficacy and safet of nateglinide
in renal transplanta recipients with posttransplant diabetes mellitus or impaired glucose
tolerance. Primarily will the change in glucose tolerance and acute insuline responce be
addressed.